Última actualización 8 de julio de 2026
Key finding
Pre-post measures of HRQOL were collected at baseline and 6 months.
This pilot study evaluated the Type 1 Diabetes and Life (T1DAL) intervention aimed at improving health-related quality of life in individuals with Type 1 diabetes.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This pilot study evaluated the Type 1 Diabetes and Life (T1DAL) intervention aimed at improving health-related quality of life in individuals with Type 1 diabetes.
Understanding the impact of behavioral interventions on health-related quality of life is crucial for improving care strategies for individuals with Type 1 diabetes. This study contributes to the ongoing exploration of effective support mechanisms for managing diabetes, although the unclear effectiveness highlights the need for further research.
Lack of detailed reporting on recruitment and retention rates. Unclear effectiveness of the intervention due to insufficient data. No specific results on participant satisfaction or qualitative interviews. Non-randomized design may limit generalizability.
Published in
Publication details and source links for this paper.
Marisa EH, Wendy L, Ruth SW, et al. Pilot Study of a Brief Behavioral Intervention Targeting Health-Related Quality of Life in Type 1 Diabetes. Contemporary Clinical Trials Communications. 2025;45:101491. doi:10.1016/j.conctc.2025.101491
Health-related quality of life was measured but results were unclear.
Recruitment and retention rates were collected but not detailed.
Intervention fidelity was monitored without specific results.
Satisfaction surveys were conducted but findings were not reported.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Type 1 Diabetes and Life (T1DAL) intervention and Fidelity of mHealth intervention, Health-related quality of life, Qualitative feedback on behavioral intervention, and 2 more.
This study contributes evidence to
Primary intervention
Type 1 Diabetes and Life (T1DAL) intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
0
Related topics
5
Evidence pairs
0
Related studies
Core evidence
The primary outcomes reported in this study.
Type 1 Diabetes and Life (T1DAL) intervention → Fidelity of mHealth intervention
Type 1 Diabetes and Life (T1DAL) intervention → Fidelity of mHealth intervention
Type 1 Diabetes and Life (T1DAL) intervention → Health-related quality of life
Type 1 Diabetes and Life (T1DAL) intervention → Health-related quality of life
Type 1 Diabetes and Life (T1DAL) intervention → Qualitative feedback on behavioral intervention
Type 1 Diabetes and Life (T1DAL) intervention → Qualitative feedback on behavioral intervention
Type 1 Diabetes and Life (T1DAL) intervention → Recruitment/enrollment/retention rates
Type 1 Diabetes and Life (T1DAL) intervention → Recruitment/enrollment/retention rates
Type 1 Diabetes and Life (T1DAL) intervention → Treatment satisfaction
Type 1 Diabetes and Life (T1DAL) intervention → Treatment satisfaction
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Type 1 Diabetes and Life (T1DAL) intervention and Fidelity of mHealth intervention, Type 1 Diabetes and Life (T1DAL) intervention and Quality of Life Outcomes.
This study contributes to the evidence on the following intervention-outcome relationships.
Behavioral & Lifestyle
Behavioral & Lifestyle
Curated evidence collections and hubs this study is part of.
All studies measuring Fidelity of mHealth intervention
Measures Fidelity of mHealth intervention as a key outcome.
All studies measuring Quality of Life Outcomes
Measures Quality of Life Outcomes as a key outcome.
All studies on Type 1 Diabetes and Life (T1DAL) intervention
Contributes to Type 1 Diabetes and Life (T1DAL) intervention evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Type 1 Diabetes and Life (T1DAL) intervention appears to improve Health-related quality of life.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Health-related quality of life
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Type 1 Diabetes and Life (T1DAL) intervention for Fidelity of mHealth intervention.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fidelity of mHealth intervention
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Type 1 Diabetes and Life (T1DAL) intervention for Qualitative feedback on behavioral intervention.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Qualitative feedback on behavioral intervention
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Type 1 Diabetes and Life (T1DAL) intervention for Recruitment/enrollment/retention rates.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Recruitment/enrollment/retention rates
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
